Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. These include coronary stents, carotid stents, peripheral stents, bioresorbable or bioabsorbable stents, and renal stents. News included clinical trial data and new technology advances in stents.

Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Artery Disease (PAD) | June 07, 2016
Intact Vascular Commences TOBA III European Clinical Trial

June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III)...
read more
News | Stents Bioresorbable | June 06, 2016
Amaranth Medical Completes Enrollment in RENASCENT-II Study

June 6, 2016 — Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel...
read more
Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016
ORIENT Trial Results on Orsiro Hybrid Drug-Eluting Stent Presented at EuroPCR 2016

June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...
read more
congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart | May 31, 2016
Stenting of Narrow Pulmonary Artery Benefits Congenital Heart Patients

May 31, 2016 — In a recent study, the use of a ...
read more
Biotronik, Magmaris bioresorbable magnesium scaffold, BIOSOLVE-II Trial, 12-month results, EuroPCR 2016
News | Stents Bioresorbable | May 17, 2016
Magmaris Bioresorbable Magnesium Scaffold Shows Long-Term Safety in BIOSOLVE-II Trial

May 17, 2016 — Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016...
read more

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016
Cordis Returns to Drug-eluting Stent Market

May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...
read more
TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Artery Disease (PAD) | May 05, 2016
Positive Twelve-Month TOBA-BTK Results Presented at SCAI 2016

May 5, 2016 — Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon...
read more
Technology | Stents Peripheral | April 27, 2016
Veniti Completes First Use of Novel Venous Stent System

April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...
read more
Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting | April 21, 2016
Medtronic Announces Early RevElution Trial Data on Drug-Filled Stent at ACC.16

April 21, 2016 — Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its...
read more
STEMI, delayed or deferred stent implantation, DANAMI-3-DEFER trial, ACC.16
News | Cath Lab | April 18, 2016
Deferred Stenting Shows No Clinical Benefit for STEMI Patients

April 18, 2016 — Delayed or deferred stent...
read more
Absorb, bioresorbable stents
Feature | Stents Bioresorbable | April 13, 2016 | Dave Fornell
Questions Remain on Future of Bioresorbable Stents

Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings...
read more
Videos | Stents Bioresorbable | April 12, 2016
VIDEO: Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries

Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New...
read more
Medinol, NIRTRAKS Study, NIRxcell Stent System, first patient

Image courtesy of Medinol

News | Stents | March 24, 2016
NIRTRAKS Study of Novel Coronary Stent Enrolls First Patient

March 24, 2016 — Medinol announced the enrollment of their first patient in the U.S. NIRTRAKS Study. NIRTRAKS is a...
read more
PinnacleHealth Cardiovascular Institute, TOBA II study, first patient, Tack Endovascular System, PAD
News | Peripheral Artery Disease (PAD) | March 22, 2016
First Pennsylvania Patient Treated in TOBA II Study

March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...
read more
Boston Scientific, Eluvia vascular stent system, CE Mark, peripheral artery disease
News | Stents Peripheral | March 17, 2016
Boston Scientific Receives CE Mark For Eluvia Drug-Eluting Vascular Stent

March 17, 2016 — Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init